This article was originally published in The Gray Sheet
Executive SummaryFirm's Ontrak Testcup-ER drug testing device gains FDA market go-ahead for use in assessing the drug-use status of emergency room patients, the firm reports Dec. 11. Intended to detect use of cocaine, morphine, amphetamines, barbiturates, and benzodiazopenes in emergency room settings, the integrated urine collection device and drug screening assay can provide "positive or negative results in less than five minutes," Roche claims
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.